Skip to content

Cerebrolysin: Side Effects & Safety

Part of the Cerebrolysin Complete Guide

Partner

Research Peptides

BioLongevity Labs15% Off
Shop Peptides at BioLongevity Labs

We may earn a commission if you purchase through this link, at no extra cost to you.

Common Side Effects

Cerebrolysin has a favorable safety profile with most side effects mild and transient:

Side EffectFrequencySeverityManagement
Injection site pain (IM)Common (10–20%)MildRotate sites, split large volumes
HeadacheOccasional (5–10%)MildResolves within hours
DizzinessOccasional (3–8%)MildTransient; more common during IV
NauseaUncommon (2–5%)MildEat before treatment
InsomniaUncommon (1–3%)MildAdminister in morning
AgitationRare (1–2%)Mild–moderateMore common in dementia patients

In CASTA and CARS trials, adverse event rates in the Cerebrolysin group were comparable to placebo.

Serious & Rare Side Effects

  • Allergic reactions: Cerebrolysin is porcine-derived. Patients with hypersensitivity to pork products should not use it. Anaphylaxis is extremely rare
  • Seizures: Theoretical concern about seizure threshold lowering in patients with pre-existing epilepsy
  • Fever: Rarely reported; may indicate immune response to porcine peptides
  • Cardiovascular: No significant cardiovascular adverse events attributed to Cerebrolysin in clinical trials

Serious adverse event rates were not significantly different between Cerebrolysin and placebo in both CARS (n=208) and CASTA (n=1,070) trials.

Contraindications & Precautions

Cerebrolysin should not be used in:

  • Epilepsy: Particularly uncontrolled seizure disorders. Status epilepticus is a specific contraindication
  • Severe renal impairment
  • Allergic diathesis: History of severe reactions to porcine-derived products
  • Pregnancy and breastfeeding: Safety not established

Precautions:

  • Monitor for hypersensitivity during first administration
  • IV infusion should be slow (15–60 minutes)
  • Do not mix with solutions containing divalent cations (calcium, magnesium)

Safety vs. Alternative Nootropics

  • vs. Semax: Semax is intranasal with minimal side effects. Cerebrolysin requires injection with injection-site reactions and rare allergic risk
  • vs. Dihexa: Dihexa has very limited human safety data. Cerebrolysin has decades of clinical use across thousands of patients
  • vs. Selank: Selank is intranasal with minimal side effects and different mechanism (anxiolytic + immune modulation)

Return to the Cerebrolysin overview or see the dosage guide.

Frequently Asked Questions

References

  1. Heiss WD, et al.. CASTA trial. Stroke, 2012.
  2. Muresanu DF, et al.. CARS trial. Stroke, 2016.

Researching peptides? We did the hard part.

Get our free Peptide Starter Kit — the 5 most researched compounds, simplified into one actionable guide.

Related Guides

PI

Peptides Insider Editorial Team

Our content is reviewed for accuracy and grounded in peer-reviewed research where available. We do not provide medical advice. Always consult a qualified healthcare professional.